NasdaqCM - Delayed Quote USD

ASP Isotopes Inc. (ASPI)

4.5200 +0.1000 (+2.26%)
At close: May 17 at 4:00 PM EDT
4.7000 +0.18 (+3.98%)
After hours: May 17 at 7:59 PM EDT
Loading Chart for ASPI
DELL
  • Previous Close 4.4200
  • Open 4.3200
  • Bid 4.5000 x 100
  • Ask 4.5800 x 300
  • Day's Range 4.3200 - 5.0800
  • 52 Week Range 0.3010 - 5.0800
  • Volume 1,731,666
  • Avg. Volume 715,355
  • Market Cap (intraday) 233.968M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -0.5300
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 5.50

ASP Isotopes Inc., a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc. was incorporated in 2021 and is headquartered in Washington, District Of Columbia.

aspisotopes.com

76

Full Time Employees

December 31

Fiscal Year Ends

Chemicals

Industry

Recent News: ASPI

Performance Overview: ASPI

Trailing total returns as of 5/17/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

ASPI
152.51%
S&P 500
11.18%

1-Year Return

ASPI
904.44%
S&P 500
29.04%

3-Year Return

ASPI
40.37%
S&P 500
34.04%

5-Year Return

ASPI
40.37%
S&P 500
34.04%

Compare To: ASPI

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ASPI

Valuation Measures

Annual
As of 5/17/2024
  • Market Cap

    233.97M

  • Enterprise Value

    234.16M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    131.06

  • Price/Book (mrq)

    22.24

  • Enterprise Value/Revenue

    183.89

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -37.78%

  • Return on Equity (ttm)

    -157.54%

  • Revenue (ttm)

    1.27M

  • Net Income Avi to Common (ttm)

    -19.62M

  • Diluted EPS (ttm)

    -0.5300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    23.89M

  • Total Debt/Equity (mrq)

    184.90%

  • Levered Free Cash Flow (ttm)

    -1.84M

Research Analysis: ASPI

Company Insights: ASPI

Research Reports: ASPI

People Also Watch